- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04567277
Early Ventriculo-peritoneal Shunt in Subarachnoid Patients With External Ventricular Drainage (EarlyVPS)
Study Overview
Status
Intervention / Treatment
Detailed Description
This study was performed on patients diagnosed with high grade SAH (WFNS 4-5) who undergo EVD within 24 hours of their admission. The conversion of EVD to VPS is performed within 7-10 days of EVD insertion, defined as early VPS group. The ventricular catheter is inserted in lateral ventricle using the same burr hole of EVD or the contralateral Kocher's point. All ruptured aneurysms could be closed by endovascular techniques or surgery.
The goal is to discontinuing EVD or its conversion to VPS within 7 to 10 days of insertion. At day 5-7 of EVD insertion, the EVD level is elevated from 15 cmH2O to 25 centimeter of water (cmH2O) gradually. The patients is evaluated during the 48 hours for cerebrospinal fluid (CSF) volume discharge, neurological consciousness, and hydrocephalus within brain CT scan acquired at the end of 48 hours of observation. If the daily CSF fluid discharge will be greater than 100 ml, brain CT scan shows evidence of HCP, there is any CSF leak from around the catheter, or the patient experiences GCS drop for 2 points or more, EVD is converted to VPS.
EVD conversion to VPS is postponed if there is any evidence of CSF infection within the last CSF analysis obtained 48 hours before VPS placement, patient experiences fever (>38.5° C) without any other source, or there is any evidence of severe vasospasm in transcranial Doppler (TCD) imaging or brain CT angiography. Otherwise, The EVD is discontinued.
For all patients, a brain CT scan is taken to evaluate the location of shunt 24 hours after VPS placement. Forty-eight hours after VPS placement, lumbar puncture (LP) is performed to collect CSF for ruling out the possibility of shunt infection or ventriculitis. Shunt malfunction (approved by imaging or signs of HCP) is reported if it occurred within 3 months of VPS placement.
When VPS malfunction is diagnosed it is revised. CSF infection is considered if there is a positive culture or ratio of CSF white blood cell count (WBC)/ red blood cell count (RBC) to blood WBC/RBC was more than 3. All patients is evaluated for clinical condition using modified Rankin scale (mRs) at discharge and 6 months later.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Mashhad, Iran, Islamic Republic of
- Ghaem Hospital, Mashhad University of Medical Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients with SAH and World Federation of Neurosurgeon (WFNS) Grade 4 or 5 and
- patient who underwent ventriculostomy (EVD insertion) within 24 hours of SAH onset.
Exclusion Criteria:
- patients with Glasgow Coma Scale of (GCS) 3 and fixed non-reactive pupils,
- patients in whom EVD was inserted in the other hospital,
- patients were successfully weaned from EVD with 7-10 days of EVD insertion
- patients who died during hospitalization.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Early VPS
|
EVD in high grade SAH patients were converted into VPS with 7-10 days of EVD insertion
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
rate of ventriculo-peritoneal malfunction
Time Frame: 3 months
|
VPS is defined malfunction when signs of hydrocephalus are seen in imaging (CTS or MRI)/clinical findings
|
3 months
|
|
rate of ventricle-peritoneal infection
Time Frame: 3 months
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
RBC / protein level in CSF association with VPS malfunction
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- T5097
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Subarachnoid Hemorrhage
-
Region StockholmKarolinska InstitutetRecruitingCerebral Vasospasm After Subarachnoid Hemorrhage | Subarachnoid Aneurysm HemorrhageSweden
-
The George InstituteTianjin Medical University General HospitalNot yet recruitingSubarachnoid Hemorrhage | Subarachnoid Hemorrhage, Aneurysmal | Aneurysmal Subarachnoid Hemorrhage | Hemorrhage, Aneurysmal SubarachnoidChina
-
Beijing Tiantan HospitalTianjin Medical University General Hospital; Development Center for Medical...Not yet recruitingAneurysmal Subarachnoid Hemorrhage | Aneurysmal Subarachnoid Hemorrhage (aSAH)China
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingSubarachnoid Hemorrhage, Aneurysmal | Subarachnoid Hemorrhage, SpontaneousItaly
-
Medical University InnsbruckRecruitingSubarachnoid Hemorrhage | Subarachnoid Hemorrhage, Aneurysmal | Aneurysmal Subarachnoid Hemorrhage | Vasospasm, CerebralAustria
-
IRCCS San RaffaeleFondazione Policlinico Universitario Agostino Gemelli IRCCS; Azienda Ospedaliera... and other collaboratorsRecruitingSubarachnoid Hemorrhage, Aneurysmal | Poor Grade Subarachnoid HemorrhageItaly
-
Assiut UniversityCompletedPost-Traumatic Subarachnoid HemorrhageEgypt
-
University of AlbertaUniversity Health Network, Toronto; Canadian Institutes of Health Research... and other collaboratorsRecruitingSubarachnoid Hemorrhage, Aneurysmal | Subarachnoid Aneurysm HemorrhageUnited States, Canada
-
Methodist Health SystemRecruitingTraumatic Intracranial Subarachnoid HemorrhageUnited States
-
Central Hospital, Nancy, FranceNot yet recruitingSubarachnoid Hemorrhage, AneurysmalFrance
Clinical Trials on External ventricular drainage (EVD) conversion into ventriculo-peritoneal shunt (VPS)
-
University Hospital Hradec KraloveCompletedBrain Damage | Hydrocephalus, Normal Pressure | Biochemical Lesions Head RegionCzechia
-
University Hospital Hradec KraloveCompletedHydrocephalus | Normal Pressure Hydrocephalus | Normal Pressure Hydrocephalus PatientsCzech Republic
-
University Hospital Hradec KraloveCompletedBrain Damage | Hydrocephalus | General Anesthetics ToxicityCzechia